Company Filing History:
Years Active: 2008-2009
Title: Innovations by Mark Porter
Introduction
Mark Porter is an accomplished inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the area of toxicity assessment. With a total of five patents to his name, Porter has developed innovative methods that enhance drug screening processes.
Latest Patents
One of his latest patents is titled "Methods for determining hepatotoxins." This invention focuses on elucidating global changes in gene expression and identifying toxicity markers in tissues or cells exposed to known toxins. The genes identified can serve as toxicity markers in drug screening and toxicity assays. Additionally, the invention includes a comprehensive database of genes characterized by toxin-induced differential expression, designed for use with microarrays and other solid-phase probes. Another notable patent is "Primary rat hepatocyte toxicity modeling," which shares similar objectives and methodologies, further emphasizing Porter's expertise in this critical area of research.
Career Highlights
Mark Porter is currently employed at Ocimum Biosolutions, Inc., where he continues to push the boundaries of innovation in biotechnology. His work has been instrumental in advancing the understanding of hepatotoxicity and improving drug safety assessments.
Collaborations
Throughout his career, Porter has collaborated with notable colleagues, including Donna Mendrick and Kory Johnson. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Mark Porter is a prominent inventor whose work in toxicity assessment has led to significant advancements in drug screening methodologies. His contributions continue to impact the field of biotechnology positively.